34 results
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
by, and delivered their report thereon in compliance with, the Securities Act and the Public Company Accounting Oversight Board (United States) (“PCAOB
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
the Chairman can focus on leading the Board in its fundamental role of providing advice to and independent oversight of management. Specifically, the Chair … director due to her employment as Chief Executive Officer of the Company.
Board Oversight of Risk Management
Our management is primarily responsible
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
and manufacturers of medicinal products are subject to comprehensive regulatory oversight by the EMA, the European Commission and/or the competent … applicable regulatory authorities’ legal requirements, regulations and guidelines, and remain subject to oversight by these governmental agencies and ethics
F-3/A
6d01ljyg7w c7jnhq
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm
F-3/A
idp642907hhh fyvq0oc
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
hvkz6geknblb
5 Aug 21
Shelf registration (foreign)
4:33pm
F-3
EX-1.2
uype0
5 Aug 21
Shelf registration (foreign)
4:33pm
6-K
EX-1.1
xiakc5s3w
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
424B5
hdrtchot fz1va4h
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
rw7pe
9 Feb 21
Prospectus supplement for primary offering
5:24pm
424B5
szyr7ocvf5wea5i
23 Oct 20
Prospectus supplement for primary offering
4:40pm
F-3
EX-1.2
bk6d 4g8tqnf4a
6 Oct 20
Shelf registration (foreign)
4:25pm
F-3
f6h2hd3vp4hpnd mnm2
6 Oct 20
Shelf registration (foreign)
4:25pm
F-3
qqtu8ln 64zejg
6 Jul 20
Shelf registration (foreign)
4:58pm
POS AM
fq7hnot9gz525 y37
2 Jul 20
Prospectus update (post-effective amendment)
3:57pm